Authors:
SMITH RH
MICHEJDA CJ
HUGHES SH
ARNOLD E
JANSSEN PAJ
SMITH MBK
Citation: Rh. Smith et al., STRUCTURE AND MECHANISM OF ACTION OF NONNUCLEOSIDE INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE - STRATEGIES TO COMBAT DRUG-RESISTANCE, Journal of molecular structure. Theochem, 423(1-2), 1998, pp. 67-77
Authors:
MOEREELS H
LEWI PJ
DAEYAERT F
SCHENCK E
JANSSEN PAJ
Citation: H. Moereels et al., THE ALPHA AND OMEGA OF G-PROTEIN COUPLED RECEPTORS - A NOVEL METHOD FOR CLASSIFICATION PART-2 BIN CLASSIFICATION, Receptors & channels, 5(3-4), 1997, pp. 139-148
Authors:
SMITH MBK
MICHEJDA CJ
HUGHES SH
BOYER PL
JANSSEN PAJ
ANDRIES K
BUCKHEIT RW
SMITH RH
Citation: Mbk. Smith et al., MOLECULAR MODELING OF HIV-1 REVERSE-TRANSCRIPTASE DRUG-RESISTANT MUTANT STRAINS - IMPLICATIONS FOR THE MECHANISM OF POLYMERASE ACTION, Protein engineering, 10(12), 1997, pp. 1379-1383
Authors:
MOEREELS H
LEWI PJ
KOYMANS LMH
JANSSEN PAJ
Citation: H. Moereels et al., THE ALPHA AND OMEGA OF G-PROTEIN COUPLED RECEPTORS - A NOVEL METHOD FOR CLASSIFICATION .1., Receptors & channels, 4(1), 1996, pp. 19-30
Authors:
DAS K
DING JP
HSIOU Y
CLARK AD
MOEREELS H
KOYMANS L
ANDRIES K
PAUWELS R
JANSSEN PAJ
BOYER PL
CLARK P
SMITH RH
SMITH MBK
MICHEJDA CJ
HUGHES SH
ARNOLD E
Citation: K. Das et al., CRYSTAL-STRUCTURES OF 8-CL AND 9-CL TIBO COMPLEXED WITH WILD-TYPE HIV-1 RT AND 8-CL TIBO COMPLEXED WITH THE TYR181CYS HIV-1 RT DRUG-RESISTANT MUTANT, Journal of Molecular Biology, 264(5), 1996, pp. 1085-1100
Authors:
ARNOLD E
DAS K
DING JP
HSIOU Y
TANTILLO C
ROY BM
YADAV P
ZHANG WY
LENTZ K
CLARK AD
BOYER PL
HUGHES SH
MITSUYA H
MELLORS J
KLEIM JP
ROSNER M
MOEREELS HR
KOYMANS L
ANDRIES K
PAUWELS R
JANSSEN PAJ
Citation: E. Arnold et al., THE ROLE OF NUCLEIC-ACID IN THE RESISTANCE OF HIV-1 REVERSE-TRANSCRIPTASE TO NUCLEOSIDE AND NONNUCLEOSIDE INHIBITORS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 7-7
Authors:
DEBETHUNE MP
AZIJN H
HERTOGS K
ANDRIES K
JANSSEN PAJ
PAUWELS R
Citation: Mp. Debethune et al., 8-CHLORO-TIBO (R091767) AND AZT IN COMBINATION CAN PREVENT THE APPEARANCE OF RESISTANT HIV IN-VITRO, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 15-15
Authors:
AZIJN H
DEBETHUNE MP
HERTOGS K
ANDRIES K
JANSSEN PAJ
PAUWELS R
Citation: H. Azijn et al., DESIGN OF AN EXPERIMENTAL ASSAY THAT MIGHT BE OF PROGNOSTIC VALUE FORANTI-HIV COMBINATION THERAPY, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 86-86
Authors:
DING JP
DAS K
MOEREELS H
KOYMANS L
ANDRIES K
JANSSEN PAJ
HUGHES SH
ARNOLD E
Citation: Jp. Ding et al., STRUCTURE OF HIV-1 RT TIBO R-86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS/, Nature structural biology, 2(5), 1995, pp. 407-415
Authors:
DING J
DAS K
TANTILLO C
ZHANG W
CLARK AD
JESSEN S
LU X
HSIOU Y
JACOBOMOLINA A
ANDRIES K
PAUWELS R
MOEREELS H
KOYMANS L
JANSSEN PAJ
SMITH RH
KOEPKE MK
MICHEJDA CJ
HUGHES SH
ARNOLD E
Citation: J. Ding et al., STRUCTURE OF HIV-1 REVERSE-TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA-R-95845 AT 2.8-ANGSTROM RESOLUTION, Structure, 3(4), 1995, pp. 365-379
Authors:
SMITH MBK
ROUZER CA
TANEYHILL LA
SMITH NA
HUGHES SH
BOYER PL
JANSSEN PAJ
MOEREELS H
KOYMANS L
ARNOLD E
DING JP
DAS K
ZHANG WY
MICHEJDA CJ
SMITH RH
Citation: Mbk. Smith et al., MOLECULAR MODELING STUDIES OF HIV-1 REVERSE-TRANSCRIPTASE NONNUCLEOSIDE INHIBITORS - TOTAL-ENERGY OF COMPLEXATION AS A PREDICTOR OF DRUG PLACEMENT AND ACTIVITY, Protein science, 4(10), 1995, pp. 2203-2222
Authors:
DEBRABANDER M
VANDEBROEK J
WASSENAAR H
DECREE J
BAISIER A
DEMOEN B
DERIDDER R
JAGERS E
ROELS V
VOGELS O
VERHAEGEN H
JANSSEN PAJ
Citation: M. Debrabander et al., IMMUNOLOGICAL ALTERATIONS INDUCED BY ADJUVANT TREATMENT OF POSTOPERATIVE COLON-CARCINOMA DUKES-B OR DUKES-C WITH LEVAMISOLE IN COMBINATION WITH 5-FU, Anticancer research, 15(5), 1995, pp. 2271-2277
Authors:
HAYDEN FG
HIPSKIND GJ
WOERNER DH
EISEN GF
JANSSENS M
JANSSEN PAJ
ANDRIES K
Citation: Fg. Hayden et al., INTRANASAL PIRODAVIR (R77,975) TREATMENT OF RHINOVIRUS COLDS, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 290-294
Authors:
BRESLIN HJ
KUKLA MJ
LUDOVICI DW
MOHRBACHER R
HO W
MIRANDA M
RODGERS JD
HITCHENS TK
LEO G
GAUTHIER DA
HO CY
SCOTT MK
DECLERCQ E
PAUWELS R
ANDRIES K
JANSSEN MAC
JANSSEN PAJ
Citation: Hj. Breslin et al., SYNTHESIS AND ANTI-HIV-1 ACTIVITY OF ETHYLIMIDAZO[4,5,1-JK][1,4]BENZODIAZEPIN-2(1H)-ONE (TIBO) DERIVATIVES .3., Journal of medicinal chemistry, 38(5), 1995, pp. 771-793
Authors:
HO W
KUKLA MJ
BRESLIN HJ
LUDOVICI DW
GROUS PP
DIAMOND CJ
MIRANDA M
RODGERS JD
HO CY
DECLERCQ E
PAUWELS R
ANDRIES K
JANSSEN MAC
JANSSEN PAJ
Citation: W. Ho et al., SYNTHESIS AND ANTI-HIV-1 ACTIVITY OF ETHYLIMIDAZO[4,5,1-JK][1,4]BENZODIAZEPIN-2(1H)-ONE (TIBO) DERIVATIVES .4., Journal of medicinal chemistry, 38(5), 1995, pp. 794-802
Authors:
BUCKHEIT RW
WHITE EL
GERMANYDECKER J
ALLEN LB
ROSS LJ
SHANNON WM
JANSSEN PAJ
CHIRIGOS MA
Citation: Rw. Buckheit et al., CELL-BASED AND BIOCHEMICAL-ANALYSIS OF THE ANTI-HIV ACTIVITY OF COMBINATIONS OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND ANALOGS OF TIBO, Antiviral chemistry & chemotherapy, 5(1), 1994, pp. 35-42
Authors:
VANDAMME AM
DEBYSER Z
PAUWELS R
DEVREESE K
GOUBAU P
YOULE M
GAZZARD B
STOFFELS PA
CAUWENBERGH GF
ANNE J
ANDRIES K
JANSSEN PAJ
DESMYTER J
DECLERCQ E
Citation: Am. Vandamme et al., CHARACTERIZATION OF HIV-1 STRAINS ISOLATED FROM PATIENTS TREATED WITHTIBO R82913, AIDS research and human retroviruses, 10(1), 1994, pp. 39-46
Authors:
PAUWELS R
ANDRIES K
DEBYSER Z
KUKLA MJ
SCHOLS D
BRESLIN HJ
WOESTENBORGHS R
DESMYTER J
JANSSEN MAC
DECLERCQ E
JANSSEN PAJ
Citation: R. Pauwels et al., NEW YDROIMIDAZO[4,5,1-JK][1,4]-BENZODIAZEPIN-2(1H)-ONE AND OIMIDAZO[4,5,1-JK][1,4]-BENZODIAZEPIN-2(1H)-THIONE DERIVATIVES ARE POTENT INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION AND ARE SYNERGISTIC WITH 2',3'-DIDEOXYNUCLEOSIDE ANALOGS, Antimicrobial agents and chemotherapy, 38(12), 1994, pp. 2863-2870
Citation: F. Declerck et al., INHIBITION OF 5-HYDROXYTRYPTAMINE-INDUCED AND 5-HYDROXYTRYPTAMINE-AMPLIFIED HUMAN PLATELET-AGGREGATION BY KETANSERIN (R-41-468), A SELECTIVE 5-HT(2)-RECEPTOR ANTAGONIST, Agents and actions, 43(3-4), 1994, pp. 225-234
Authors:
TANTILLO C
DING JP
JACOBOMOLINA A
NANNI RG
BOYER PL
HUGHES SH
PAUWELS R
ANDRIES K
JANSSEN PAJ
ARNOLD E
Citation: C. Tantillo et al., LOCATIONS OF ANTI-AIDS DRUG-BINDING SITES AND RESISTANCE MUTATIONS INTHE 3-DIMENSIONAL STRUCTURE OF HIV-1 REVERSE-TRANSCRIPTASE - IMPLICATIONS FOR MECHANISMS OF DRUG-INHIBITION AND RESISTANCE, Journal of Molecular Biology, 243(3), 1994, pp. 369-387
Citation: Paj. Janssen et Fhl. Awouters, IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTICS FROM ANIMAL DATA .5. FROM HALOPERIDOL AND PIPAMPERONE TO RISPERIDONE, Arzneimittel-Forschung, 44-1(3), 1994, pp. 269-277
Authors:
BUCKHEIT RW
GERMANYDECKER J
HOLLINGSHEAD MG
ALLEN LB
SHANNON WM
JANSSEN PAJ
CHIRIGOS MA
Citation: Rw. Buckheit et al., DIFFERENTIAL ANTIVIRAL ACTIVITY OF 2 TIBO DERIVATIVES AGAINST THE HUMAN IMMUNODEFICIENCY AND MURINE LEUKEMIA VIRUSES ALONE AND IN COMBINATION WITH OTHER ANTI-HIV AGENTS, AIDS research and human retroviruses, 9(11), 1993, pp. 1097-1106
Authors:
AWOUTERS F
MEGENS A
VERLINDEN M
SCHUURKES J
NIEMEGEERS C
JANSSEN PAJ
Citation: F. Awouters et al., LOPERAMIDE - SURVEY OF STUDIES ON MECHANISM OF ITS ANTIDIARRHEAL ACTIVITY, Digestive diseases and sciences, 38(6), 1993, pp. 977-995
Authors:
LEYSEN JE
JANSSEN PMF
GOMMEREN W
WYNANTS J
PAUWELS PJ
JANSSEN PAJ
Citation: Je. Leysen et al., INVITRO AND INVIVO RECEPTOR-BINDING AND EFFECTS ON MONOAMINE TURNOVERIN RAT-BRAIN REGIONS OF THE NOVEL ANTIPSYCHOTICS RISPERIDONE AND OCAPERIDONE, Molecular pharmacology, 41(3), 1992, pp. 494-508